ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

SIGY Sigyn Therapeutics Inc (QB)

5.40
0.00 (0.00%)
04 Dec 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2023 2017201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 1.28M28k143k0000
Operating Income -2.43M-1M-518k-917k-2.01M-2.15M-2.46M
Pre Tax Income -4.25M-2.3M-3.31M-1.26M-3.01M-2.93M-4.15M
Net Income -4.25M-2.62M-3.08M-1.26M-3.01M-2.93M-4.15M
Preferred Dividends 0000000
Basic Earnings Per Share (EPS) -0.08-0.032-0.038-0.036-0.081-0.079-0.08
EBIT -3.13M-1.54M-3.26M-917k-2.01M-2.15M-2.74M
EBITDA -2.2M-756k-443k-906k-1.99M-2.14M-2.45M

Your Recent History

Delayed Upgrade Clock